Dendreon DNDN Halted - News Pending 4/14/09

Dendreon ( DNDN ) shares are halted tonight, this happened right before 5pm Est. This is a T1 halt which means News Pending.

I will have an update when the news hits! I'm sure this has something to do with their Cancer Drug Provenge.

Update: 5:55pm EST

Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial

Dendreon Corporation (Nasdaq: DNDN) will host a conference call tomorrow, Tuesday, April 14, 2009, at 9:00 AM ET (6:00 AM PT) to review the outcome of the FINAL analysis of its IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B) clinical trial of PROVENGE(R) (sipuleucel-T), the Company's investigational active cellular immunotherapy for the treatment of advanced prostate cancer.

http://investor.dendreon.com/ReleaseDetail.cfm?ReleaseID=376909&Header=News

DNDN Stock will most likely remain halted until the news hits tomorrow. This stock is either headed to $10-$15 or $2 in my opinion. We'll See!

Update 4/14/09: Looks like Provenge data was positive, stock could open at $15-$20

http://finance.yahoo.com/news/Dendreon-cancer-drug-meets-apf-14918879.html

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free